The integration of AI has the potential to enhance oncology clinical pathways, but there are important judgment calls that must be made before this technology can be fully implemented. The quest to ...
A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.
Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...
Founded in 2005 by Dr. Shishuka Malhotra, NBR was created to foster a research environment that is scientifically rigorous while remaining attuned to the needs of the community it serves.
When your parents instill certain interests in their kids, they're setting them up for success. Whether it's reading or ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
New genetic research has identified a direct causal chain connecting the microorganisms in the human digestive tract to the ...
As we enter a new year, social media feeds are often flooded with ‘vision boards’ that highlight collages of dream cars, ...
From expanding guaranteed pathways to high-demand careers and celebrating philanthropic support to strengthening workforce ...